PULMONARY ARTERIAL HYPERTENSION – A CHALLENGE FOR RESPIRATORY REHABILITATION

  • Doina-Clementina COJOCARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • R.D. NEGRU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • S. UNGURIANU “Dunǎrea de Jos” University, Galați
  • B.M. CIUNTU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Elena SARAMET Clinical Rehabilitation Hospital, Iași
  • F.D. PETRARIU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Paraschiva POSTOLACHE “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

Chronic pulmonary arterial hypertension (PAH) is a severe disease of the pulmonary vasculature, characterized by increased resistance at this level, and increased pulmonary artery pressure, ultimately leading to right heart failure and death. The current therapeutic strategy in PAH includes a stepwise approach, the first step being supportive therapy, supervised rehabilitation program, and psychosocial support, followed by pharmacological treatment according to the vasoreactive or nonreactive type of PAH and prognostic determinants. Small trials have shown that PAH patients experience reduced dyspnea and fatigue, as well as a higher level of physical activity, a greater distance to the 6-minute walk test, and improvement in the quality of life after completing a pulmonary rehabilitation program. Low-level graded endurance and resistance exercises, as well as inspiratory and peripheral muscles training, are recommended, along with careful patients’ education regarding their own illness, nutrition, and safe level of physical effort. The optimal type of physical activity, intensity, and duration of training are issues still under debate.

Author Biographies

Doina-Clementina COJOCARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)
Clinical Rehabilitation Hospital, Iași

R.D. NEGRU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)

S. UNGURIANU, “Dunǎrea de Jos” University, Galați

Department of Surgery

B.M. CIUNTU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Surgery (I)

F.D. PETRARIU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Preventive Medicine and Interdisciplinarity

Paraschiva POSTOLACHE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)
Clinical Rehabilitation Hospital, Iași

References

1. McLaughlin VV, Humberg M. Pulmonary Hypertension. In: Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine 10th. Elsevier Saunders, 2015, 1682-1702.
2. Nemes RM, Duceac LD, Vasincu EG, Agop M, Postolache P. On the Implications of the Biological Systems Fractal Morpho-Functional Structure. UPB Sci Bull, Series A 2015; 77(4): 263-272.
3. Postolache P, Duceac LD, Vasincu EG, Agop M, Nemeş RM. Chaos and self-structuring behaviors in lung airways. UPB Sci Bull, Series A 2016; 78(1): 291-298.
4. Leggio M, Fusco A, Limongelli G, Sgorbini L. Exercise training in patients with pulmonary and systemic hypertension:A unique therapy for two different diseases. Eur J Intern Med 2018; 47: 17-24.
5. Postolache P, Cojocaru DC. Pulmonary Rehabilitation - from Guidelines to Practice, Rev Med Chir Soc Med Nat Iasi 2013; 117(2): 380-387.
6. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al. 2015 ESC/ERC Guideline for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Pediatric and Congenital Car-diology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37(1): 67-119.
7. McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of Pulmonary Arterial Hypertension. JACC 2015; 65(18): 1976-1997.
8. Aslan GK, Akinci B, Yeldan I, Okumus G. Respiratory muscle strength in patients with pulmonary hypertension: The relationship with exercise capacity, physical activity level, and quality of life. Clin Respir J 2018; 12(2): 699-705.
9. Jimborean G, Ianosi ES, Croitoru A, Szasz S, Postolache P. Respiratory muscle training in chronic obstructive pulmonary disease. Pneumologia 2017; 66(3): 128-130.
10. Babu AS, Arena R, Morris NR. Evidence on Exercise Training in Pulmonary Hypertension. Adv Exp Med Biol 2017; 1000: 153-172.
11. Leggio M, Fusco A, Armeni M, D'Emidio S, Severi P, Calvaruso S et al. Pulmonary hypertension and exercise training: a synopsis on the more recent evidences. Ann Med 2018; 50(3): 226-233.
12. Pandey A, Garg S, Khunger M, Kumbhani DJ, Chin KM, Berry JD. Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis. Circ Heart Fail 2015; 8(6): 1032-1043.
13. Buys R, Avila A, Cornelissen VA. Exercise training improves physical fitness in patients with pul-monary arterial hypertension: a systematic review and meta-analysis of controlled trials. BMC Pulm Med 2015; 15(40): 1-9.
14. de Man FS, Handoko ML, Groepenhoff H, van 't Hul AJ, Abbink J, Koppers RJ et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2009; 34(3): 669-675.
15. Grünig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J et al. Effect of exercise and respir-atory training on clinical progression and survival in patients with severe chronic pulmonary hyper-tension. Respiration 2011; 81(5): 394-401.
16. Bussotti M, Gremigni P, Pedretti RFE, Kransinska P, Di Marco S, Corbo P et al. Effects of an Outpa-tient Service Rehabilitation Programme in Patients Affected by Pulmonary Arterial Hypertension: An Observational Study. Cardiovasc Hematol Disord Drug Targets 2017; 17(1): 3-10.
17. Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, ran-domized, controlled trial. Eur Heart J 2016; 37(1): 35-44.
18. Ley S, Fink C, Risse F, Ehlken N, Fischer C, Ley-Zaporozhan J et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. Eur Radiol 2013; 23(2): 324-331.
19. Keusch S, Turk A, Saxer S, Ehlken N, Grunig E, Ulrich S et al. Rehabilitation in patients with pul-monary arterial hypertension. Swiss Med Wkly 2017; 147: w14462.
20. Weatherald J, Farina S, Bruno N, Laveneziana P. Cardiopulmonary Exercise Testing in Pulmonary Hypertension. Ann Am Thorac Soc 2017; 14 (Supplement1): S84-S92.
21. Inagaki T, Terada J, Yahaba M, Kawata N, Jujo T, Nagashima K et al. Heart Rate and Oxygen Satu-ration Change Patterns During 6-min Walk Test in Subjects with Chronic Thromboembolic Pulmonary Hypertension. Respir Care 2018; 63(5): 573-583.
22. González-Saiz L, Fiuza-Luces C, Sanchis-Gomar F, Santos-Lozano A, Quezada-Loaiza CA, Flox-Camacho A et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi+12 trial. Int J Cardiol 2017; 231: 277-283.
23. Madden BP, Shaw EJ. Skeletal muscle exercise training in pulmonary arterial hypertension. Int J Cardiol 2017; 246: 59-60.
24. Brown MB, Kempf A, Collins CM, Long GM, Owens M, Gupta S et al. A prescribed walking regi-men plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study. Pulm Circ 2018; 8(1): 2045893217743966.
25. Graarup J, Ferrari P, Howard LS. Patient engagement and self-management in pulmonary arterial hypertension. Eur Respir Rev 2016; 25(142): 399-407.
Published
2018-06-29
Section
INTERNAL MEDICINE - PEDIATRICS